ROCHESTER, Minn.--(BUSINESS WIRE)--In a paper published today, a team of medical researchers from the Mayo Clinic in collaboration with academic colleagues from Myriad Genetics Laboratories, the University of Utah, France, and Australia report on the outcome of a study that analyzes the risk for breast cancer imparted by inherited mutations in the BRCA2 gene.
